{"id":"https://openalex.org/W7225757022","doi":"https://doi.org/10.1002/bcp.70915","title":"Mechanistic insights into vincristine interactions with azoles and dasatinib: Implications for neurotoxicity in paediatric patients using physiologically based pharmacokinetic modelling","display_name":"Mechanistic insights into vincristine interactions with azoles and dasatinib: Implications for neurotoxicity in paediatric patients using physiologically based pharmacokinetic modelling","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225757022","doi":"https://doi.org/10.1002/bcp.70915","pmid":"https://pubmed.ncbi.nlm.nih.gov/43006227"},"language":"en","primary_location":{"id":"doi:10.1002/bcp.70915","doi":"https://doi.org/10.1002/bcp.70915","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bcp.70915","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102656607","display_name":"Yawen Yuan","orcid":"https://orcid.org/0000-0002-6173-3414","observed_orcids":["https://orcid.org/0000-0002-6173-3414"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I4210092101","display_name":"Shanghai Children's Medical Center","ror":"https://ror.org/00cd9s024","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210092101"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yawen Yuan","raw_affiliation_strings":["Department of Clinical Pharmacy, Shanghai Children's Medical Center, School of Medicine Shanghai Jiao Tong University  Shanghai China"],"raw_orcid":"https://orcid.org/0000-0002-6173-3414","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, Shanghai Children's Medical Center, School of Medicine Shanghai Jiao Tong University  Shanghai China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210092101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161381858","display_name":"Juan Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I4210092101","display_name":"Shanghai Children's Medical Center","ror":"https://ror.org/00cd9s024","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210092101"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Juan Wu","raw_affiliation_strings":["Department of Pharmaceutical Administration, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine  Shanghai China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Administration, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine  Shanghai China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210092101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161411669","display_name":"Jing Cao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I4210092101","display_name":"Shanghai Children's Medical Center","ror":"https://ror.org/00cd9s024","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210092101"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Cao","raw_affiliation_strings":["Department of Clinical Pharmacy, Shanghai Children's Medical Center, School of Medicine Shanghai Jiao Tong University  Shanghai China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, Shanghai Children's Medical Center, School of Medicine Shanghai Jiao Tong University  Shanghai China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210092101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161374268","display_name":"Bulong Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I4210092101","display_name":"Shanghai Children's Medical Center","ror":"https://ror.org/00cd9s024","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210092101"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bulong Xu","raw_affiliation_strings":["Department of Pharmaceutical Administration, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine  Shanghai China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Administration, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine  Shanghai China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210092101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110765459","display_name":"Mei Zheng","orcid":"https://orcid.org/0009-0009-7123-6284","observed_orcids":["https://orcid.org/0009-0009-7123-6284"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I4210092101","display_name":"Shanghai Children's Medical Center","ror":"https://ror.org/00cd9s024","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210092101"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mei Zheng","raw_affiliation_strings":["Department of Pharmaceutical Administration, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine  Shanghai China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Administration, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine  Shanghai China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210092101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069317379","display_name":"Joseph Frank Standing","orcid":"https://orcid.org/0000-0002-4561-7173","observed_orcids":["https://orcid.org/0000-0002-4561-7173"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Joseph F. Standing","raw_affiliation_strings":["Infection, Immunity, Inflammation Section UCL Institute of Child Health  London UK"],"raw_orcid":"https://orcid.org/0000-0002-4561-7173","affiliations":[{"raw_affiliation_string":"Infection, Immunity, Inflammation Section UCL Institute of Child Health  London UK","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5069317379","https://openalex.org/A5102656607"],"corresponding_institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210092101","https://openalex.org/I45129253"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.763700008392334,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.763700008392334,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.09539999812841415,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.03150000050663948,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.8030999898910522},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7084000110626221},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.67330002784729},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.5799999833106995},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.47769999504089355},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4526999890804291},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.4203999936580658},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.4194999933242798},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.39660000801086426},{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.3950999975204468},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3693999946117401},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3619000017642975},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.3596999943256378},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.3490999937057495},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.34360000491142273},{"id":"https://openalex.org/C2776239304","wikidata":"https://www.wikidata.org/wiki/Q6954915","display_name":"NONMEM","level":3,"score":0.33340001106262207},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.28189998865127563},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.26429998874664307},{"id":"https://openalex.org/C2780628323","wikidata":"https://www.wikidata.org/wiki/Q413546","display_name":"Clotrimazole","level":3,"score":0.2603999972343445},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.25859999656677246},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2581000030040741},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.2538999915122986}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1002/bcp.70915","doi":"https://doi.org/10.1002/bcp.70915","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bcp.70915","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:43006227","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43006227","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1790308478","https://openalex.org/W2023516218","https://openalex.org/W2029038568","https://openalex.org/W2032289867","https://openalex.org/W2068402403","https://openalex.org/W2084515253","https://openalex.org/W2090540550","https://openalex.org/W2095929790","https://openalex.org/W2101382220","https://openalex.org/W2117255772","https://openalex.org/W2121186334","https://openalex.org/W2127469009","https://openalex.org/W2149870684","https://openalex.org/W2151296781","https://openalex.org/W2194258360","https://openalex.org/W2320694200","https://openalex.org/W2775244032","https://openalex.org/W2804531053","https://openalex.org/W2899445963","https://openalex.org/W2922800780","https://openalex.org/W2923453543","https://openalex.org/W2945839580","https://openalex.org/W2968677711","https://openalex.org/W3044445445","https://openalex.org/W3120863947","https://openalex.org/W3156899852","https://openalex.org/W3164413398","https://openalex.org/W3203445956","https://openalex.org/W4206074822","https://openalex.org/W4211047162","https://openalex.org/W4214746391","https://openalex.org/W4283219019","https://openalex.org/W4309683822","https://openalex.org/W4384007145","https://openalex.org/W4390025027","https://openalex.org/W4390030366","https://openalex.org/W4390031134","https://openalex.org/W4390145705","https://openalex.org/W4392346206","https://openalex.org/W4394859797","https://openalex.org/W4396596250","https://openalex.org/W4401733222","https://openalex.org/W4403157488"],"related_works":[],"abstract_inverted_index":{"Aims":[0],"This":[1],"study":[2],"aimed":[3],"to":[4,32],"investigate":[5],"the":[6],"mechanisms":[7],"and":[8,20,27,36,45,59,87,93,96,109,115,118,143,185,217,228,235],"pharmacokinetic":[9,50,70],"consequences":[10],"of":[11,123,141,203,223],"vincristine":[12],"(VCR)":[13],"drug\u2013drug":[14],"interactions":[15],"(DDIs)":[16],"with":[17,176],"azole":[18],"antifungals":[19],"dasatinib":[21],"(DAS).":[22],"Methods":[23],"In":[24,194],"vitro":[25,57,195],"enzyme":[26],"transporter":[28],"assays":[29,198],"were":[30,53],"conducted":[31],"characterize":[33],"VCR":[34,68,161,188,224],"metabolism":[35],"inhibition":[37,122,140,153],"by":[38,190,206],"posaconazole":[39],"(POS),":[40],"voriconazole":[41],"(VRZ),":[42],"fluconazole":[43],"(FLZ)":[44],"DAS.":[46],"Paediatric":[47],"physiologically":[48],"based":[49],"(PBPK)":[51],"models":[52],"developed":[54],"using":[55,62,75],"in":[56,226,240],"parameters":[58],"further":[60],"refined":[61],"empirical":[63],"Bayesian":[64],"estimates":[65],"from":[66],"a":[67,200],"population":[69],"model.":[71],"Cytotoxicity":[72],"was":[73,163],"assessed":[74],"dorsal":[76],"root":[77],"ganglion":[78],"(DRG)":[79],"cell":[80,197],"assays.":[81],"Results":[82],"POS":[83,184,216],"competitively":[84,106],"inhibited":[85,107],"CYP3A4":[86,108,124,142],"CYP3A5":[88,110,144],"(":[89,98,111,154],"K\u1d62":[90,112,155],"=":[91,101,113,127,132,156,168],"1.62":[92],"1.35":[94],"\u03bcM)":[95,117],"P\u2010gp":[97],"IC":[99],"50":[100],"7.72":[102],"\u03bcM),":[103,148],"whereas":[104,149],"VRZ":[105,186,218],"8.87":[114],"4.22":[116],"additionally":[119],"exhibited":[120],"mechanism\u2010based":[121],"(K":[125],"I":[126],"16.24":[128],"\u03bcM,":[129],"k":[130],"inact":[131],"0.0263":[133],"min":[134],"\u22121":[135],").":[136],"FLZ":[137],"showed":[138,151],"weak":[139],"(K\u1d62":[145],">":[146],"60":[147],"DAS":[150],"moderate":[152],"1.99\u20134.42":[157],"\u03bcM).":[158],"The":[159],"simulated":[160],"clearance":[162],"also":[164],"approximately":[165],"halved":[166],"(CL":[167],"0.59":[169],"vs":[170],".":[171],"0.33":[172],"L/h/kg)":[173],"when":[174],"co\u2010administrated":[175],"POS.":[177,207],"Moreover,":[178],"PBPK":[179,211],"modelling":[180],"indicated":[181],"that":[182,215],"intravenous":[183],"increased":[187],"AUCs":[189],"more":[191],"than":[192],"twofold.":[193],"DRG":[196],"demonstrated":[199],"concentration\u2010dependent":[201],"potentiation":[202],"VCR\u2010induced":[204],"cytotoxicity":[205],"Conclusions":[208],"Collectively,":[209],"these":[210],"model":[212],"predictions":[213],"suggest":[214],"may":[219,229],"represent":[220],"high\u2010risk":[221],"perpetrators":[222],"DDIs":[225],"children":[227],"help":[230],"guide":[231],"future":[232],"dose":[233],"optimization":[234],"toxicity":[236],"management,":[237],"pending":[238],"confirmation":[239],"prospective":[241],"clinical":[242],"studies.":[243]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}